Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
OREX [NASD]
Orexigen Therapeutics, Inc.
Index- P/E- EPS (ttm)-0.83 Insider Own0.10% Shs Outstand122.54M Perf Week-7.56%
Market Cap584.52M Forward P/E- EPS next Y-0.35 Insider Trans-0.75% Shs Float121.58M Perf Month-17.33%
Income-89.50M PEG- EPS next Q0.06 Inst Own84.70% Short Float21.72% Perf Quarter-21.67%
Sales3.40M P/S171.92 EPS this Y37.00% Inst Trans0.58% Short Ratio7.32 Perf Half Y-35.54%
Book/sh0.00 P/B- EPS next Y-52.20% ROA-63.40% Target Price11.00 Perf Year-28.81%
Cash/sh1.09 P/C4.38 EPS next 5Y12.30% ROE-389.10% 52W Range4.50 - 7.82 Perf YTD-15.28%
Dividend- P/FCF- EPS past 5Y21.90% ROI-63.30% 52W High-39.00% Beta2.46
Dividend %- Quick Ratio5.70 Sales past 5Y102.40% Gross Margin- 52W Low6.00% ATR0.31
Employees50 Current Ratio5.70 Sales Q/Q0.00% Oper. Margin- RSI (14)32.29 Volatility6.96% 5.82%
OptionableYes Debt/Eq163.80 EPS Q/Q-10.50% Profit Margin- Rel Volume1.58 Prev Close4.89
ShortableYes LT Debt/Eq163.80 EarningsAug 07 BMO Payout- Avg Volume3.61M Price4.77
Recom1.70 SMA20-14.52% SMA50-12.26% SMA200-20.45% Volume5,706,039 Change-2.45%
10-Jan-14Initiated WallachBeth Buy $9
03-Oct-13Initiated Cowen Outperform $10
21-Sep-11Upgrade JMP Securities Mkt Perform → Mkt Outperform $5
01-Feb-11Downgrade JMP Securities Mkt Outperform → Mkt Perform
01-Feb-11Downgrade Canaccord Genuity Buy → Hold
03-Dec-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform
16-Jul-10Reiterated JMP Securities Mkt Outperform $16 → $13
16-Jul-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
02-Feb-10Initiated Jefferies & Co Buy $12
24-Jun-09Initiated Rodman & Renshaw Mkt Outperform $14
13-Mar-09Reiterated Lazard Capital Mkts Buy $13 → $10
03-Apr-08Initiated Cowen & Co Outperform
06-Feb-08Initiated Lazard Capital Buy
04-Feb-08Reiterated Canaccord Adams Buy $29 → $32
03-Jan-08Initiated JP Morgan Overweight
03-Oct-07Upgrade JMP Securities Mkt Outperform → Strong Buy $26
07-Jun-07Initiated JP Morgan Overweight
06-Jun-07Initiated JMP Securities Mkt Outperform $26
18-Sep-14 08:25AM  The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead Zacks
17-Sep-14 02:00PM  Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved Zacks
16-Sep-14 04:15PM  Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference PR Newswire
10:30AM  Insider Trading Alert - HTGC, OREX And TEP Traded By Insiders at TheStreet
15-Sep-14 06:00AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -5.43%
05:51AM  Selling Obesity Drugs to Americans Shouldn't Be This Hard at BusinessWeek
12-Sep-14 04:10PM  Novo Nordisk's Saxenda Gets Positive Opinion for Obesity Zacks
01:20PM  Nasdaq stocks posting largest percentage decreases AP
11:00AM  [video] Orexigen's anti-obesity pill wins FDA Approval at CNBC
11-Sep-14 06:02PM  Nasdaq stocks posting largest percentage decreases AP -10.51%
05:23PM  FDA panel backs Novo Nordisk injection for obesity AP
05:15PM  [video] Orexigen drops in spite of FDA approval at CNBC
04:10PM  How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval? at TheStreet
04:00PM  U.S. FDA panel: Novo Nordisk's liraglutide safe/effective for obesity Reuters
03:30PM  Orexigen's Obesity Drug Contrave Approved by the FDA Zacks
02:13PM  How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval? at TheStreet
02:09PM  Nasdaq stocks posting largest percentage decreases AP
01:49PM  FDA approves weight-loss drug Contrave AP
01:23PM  Orexigen's Obesity Pill is Approved and Stock Falls. Don't be Surprised at TheStreet
01:15PM  How Will Orexigen Therapeutics (OREX) Stock Respond to FDA's Contrave Approval? at TheStreet
01:11PM  [video] Orexigen's obesity pill at CNBC
12:50PM  [$$] FDA Approves Weight-Loss Drug at The Wall Street Journal
10:34AM  Long-awaited diet pill gets U.S. approval Reuters
10:11AM  FDA approves weight-loss drug Contrave AP
08:45AM  Long-awaited diet pill gets U.S. approval Reuters
08:42AM  [$$] FDA Approves Weight-Loss Drug at The Wall Street Journal
08:30AM  Orexigen Therapeutics Call scheduled for 8:30 am ET today CCBN
08:19AM  Orexigen Therapeutics Call scheduled for 8:30 am ET today CCBN
08:02AM  [$$] FDA Approves Weight-Loss Drug at The Wall Street Journal
07:40AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online
07:34AM  Orexigen Therapeutics Call scheduled for 8:30 am ET today CCBN
07:18AM  FDA approves weight-loss drug Contrave AP
07:00AM  Takeda and Orexigen Announce FDA Approval of Contrave┬« (naltrexone HCI and bupropion HCI) Extended-release Tablets for Chronic Weight Management PR Newswire
06:09AM  Orexigen Therapeutics Call scheduled for 8:30 am ET today CCBN
04:11AM  [$$] FDA Approves Weight-Loss Drug at The Wall Street Journal
03:35AM  [$$] FDA Approves Weight-Loss Drug at The Wall Street Journal
10-Sep-14 09:16PM  New Drug to Treat Obesity Gains Approval by F.D.A. at New York Times
09:00PM  Long-awaited diet pill gets U.S. approval Reuters
07:58PM  FDA Approves Contrave Weight Loss Drug From Orexigen And Takeda at Forbes
07:46PM  Orexigen Therapeutics to Host Conference Call and Webcast At 8:30 AM Eastern Time September 11, 2014 PR Newswire
07:00PM  Orexigen Wins U.S. FDA Approval for Weight-Loss Pill at Bloomberg
08-Sep-14 05:15PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
02-Sep-14 08:00AM  Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent PR Newswire
19-Aug-14 10:45AM  You've got obesity all wrong: Zafgen CEO at CNBC
15-Aug-14 01:04PM  OREXIGEN THERAPEUTICS, INC. Financials EDGAR Online Financials
08-Aug-14 05:13PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
08:20AM  Orexigen Therapeutics Reports Wider Q2 Loss as Costs Mount Zacks
07-Aug-14 08:00AM  Orexigen Therapeutics Inc Earnings Call scheduled for 8:00 am ET today CCBN
07:49AM  Orexigen Therapeutics Inc Earnings Call scheduled for 8:00 am ET today CCBN
07:20AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a EDGAR Online
07:07AM  Q2 2014 Orexigen Therapeutics, Inc. Earnings Release - Before Market Open CCBN
07:00AM  Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014 PR Newswire
31-Jul-14 08:00AM  Orexigen Therapeutics to Host Second Quarter 2014 Financial Results Conference Call and Webcast PR Newswire
30-Jul-14 01:21PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online
08:00AM  Orexigen Receives CHMP Day 180 List of Outstanding Issues PR Newswire
21-Jul-14 09:46AM  Perilous Reversal Watch: Orexigen Therapeutics (OREX) at TheStreet
19-Jul-14 04:14PM  The Implications of Obesity as a Disability in Europe at Motley Fool
18-Jul-14 10:09AM  Trade-Ideas: Orexigen Therapeutics (OREX) Is Today's "Dead Cat Bounce" Stock at TheStreet +5.56%
05:47AM  Call buyers returning to Orexigen optionMONSTER
15-Jul-14 06:50PM  Arena Pharmaceuticals Inc. Still Down After CEO's Sale at Motley Fool
11-Jul-14 01:01PM  Arena Stock Holds On Expected Dip In Sales - Bottom May Be In at Seeking Alpha
06:14AM  Bull throws weight behind Orexigen optionMONSTER
10-Jul-14 11:54AM  14 Insanely Important Biotech/Drug Trading Catalysts for the Rest of 2014 at TheStreet
03-Jul-14 04:11PM  3 Stocks Even Volatility-Loving Nasdaq Investors Hate at Motley Fool
04:06PM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Subm EDGAR Online
01-Jul-14 06:09PM  The Next Orphan Drug Multibagger and Future Obesity Champion? at Motley Fool
27-Jun-14 05:30PM  Are Investors Wrong About Orexigen Therapeutics? at Motley Fool
05:30PM  Are Investors Wrong About Orexigen Therapeutics?
05:01PM  3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir at Motley Fool
05:01PM  3 Biotech Stocks with Catalysts Incoming: Spectrum, Orexigen, and Avanir
25-Jun-14 05:30PM  Are Investors Wrong About VIVUS? at Motley Fool
05:30PM  Are Investors Wrong About VIVUS?
24-Jun-14 06:20AM  How Bad Is This Delay for Orexigen Therapeutics, Inc? at Motley Fool
06:20AM  How Bad Is This Delay for Orexigen Therapeutics, Inc?
20-Jun-14 11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think at Seeking Alpha
11:34AM  The Anti-Obesity Space Is Not As Simple As Some Think
03:19AM  Now Available: Shares in Zafgen, the Best Obesity Drugmaker to Date at Motley Fool
03:19AM  Now Available: Shares in Zafgen, the Best Obesity Drugmaker to Date
19-Jun-14 03:12PM  Why Zafgen Inc. Shares Roared Higher at Motley Fool
07:24AM  The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene, Alexion and Biogen Zacks
07:24AM  The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene, Alexion and Biogen
18-Jun-14 09:33AM  Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar Zacks
09:33AM  Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar
17-Jun-14 07:41AM  Orexigen (OREX) in Focus: Stock Moves 7.5% Higher Zacks
07:41AM  Orexigen (OREX) in Focus: Stock Moves 7.5% Higher
16-Jun-14 04:19PM  What Will It Take For Arena Stock To Rise? at Seeking Alpha +7.52%
04:19PM  What Will It Take For Arena Stock To Rise?
08:00AM  3 Stocks Crushed by the Market This Week at Motley Fool
08:00AM  3 Stocks Crushed by the Market This Week
15-Jun-14 11:20AM  This Week in Biotech: Actions Speak Louder Than Words at Motley Fool
11:20AM  This Week in Biotech: Actions Speak Louder Than Words
13-Jun-14 05:32PM  Is It Time to Buy Orexigen? at Motley Fool
05:32PM  Is It Time to Buy Orexigen?
02:56PM  Vivus Suit Preserves Exclusivity Of Qsymia - For Now at Seeking Alpha
02:56PM  Vivus Suit Preserves Exclusivity Of Qsymia - For Now
02:49PM  Arena's Belviq Sales Do More Than Recover at Seeking Alpha
08:30AM  Orexigen Therapeutics to Present at the Wells Fargo Securities 2014 Healthcare Conference PR Newswire
06:04AM  OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
12-Jun-14 05:30PM  Orexigen Slumps as Obesity Drug Approval Delayed Zacks
01:19PM  Nasdaq stocks posting largest percentage decreases AP
Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include NB32, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic that has completed Phase II clinical trials. Orexigen Therapeutics, Inc. has collaboration agreement with Takeda Pharmaceutical Company Limited to develop and commercialize NB32 in the United States, Canada, and Mexico. The company was founded in 2002 and is headquartered in La Jolla, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hagan Joseph PSr. VP, Corporate DevelopmentSep 15Buy4.695,00023,45013,026Sep 15 03:11 PM
NARACHI MICHAELPresident and CEOSep 15Buy4.7850,000239,10058,026Sep 15 02:41 PM
DOVEY BRIAN HDirectorApr 22Option Exercise0.004,691,4704,6917,580,065Apr 23 05:15 PM